Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Cogstate Ltd ( (AU:CGS) ) is now available.
Cogstate Ltd has announced an update on its ongoing share buy-back program, which involves the repurchase of its ordinary fully paid securities. As of April 14, 2025, the company has bought back a total of 4,678,796 securities, with an additional 90,315 securities repurchased on the previous day. This buy-back initiative is part of Cogstate’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology. The company provides cognitive assessment services and tools, primarily focusing on clinical trials and healthcare markets.
YTD Price Performance: 18.37%
Average Trading Volume: 10,383
Technical Sentiment Signal: Sell
Current Market Cap: $136M
Learn more about CGS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue